ANNXSMALL

Annexon, Inc.

HealthcareBiotechnology
$5.71
$0.00(-0.26%)
52W$1.60
$7.18
Updated May 6, 12:00 AM
RSI46
RS Rating90/99
Beta2.25
Volatility81%
F-Score3/9
Mkt Cap$624M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Annexon, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings contraction of 48% provides fundamental context to the price action. Investors should exercise caution due to high volatility (81% annualized), which requires wider risk management.

Relative Strength
90
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
2.25
vs S&P 500
HIGH BETA
52W Position
74%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$5.70
50 SMA > 100 SMA$5.63
100 SMA > 150 SMA$4.91
150 SMA > 200 SMA$4.30

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.02-5.21%BELOW
50 SMA$5.70+0.12%ABOVE
100 SMA$5.63+1.38%ABOVE
150 SMA$4.91+16.09%ABOVE
200 SMA$4.30+32.73%ABOVE

Price Performance

1D-0.3%
1W-3.1%
1M-1.6%
3M-0.4%
6M+88.9%
YTD+21.6%
1Y+245.8%
3Y+2.8%
52-Week Trading Range74% from low
$5.71
52W Low$1.60
52W High$7.18

Technical Indicators

RSI (14)NEUTRAL
46.2
305070
VCP ScoreCOOL
6/10
Base depth: 32.2%

Risk Profile

Beta
2.25
52W Vol
81%
ATR
$0.30
Max DD (1Y)
-30%

Volume Analysis

Today
1.32M
50D Avg
2.52M
Vol Ratio
0.52x
Liquidity
MODERATE

Earnings Momentum

Q4'24+8%
$-0.33
Q1'25-76%
$-0.37
Q2'25-48%
$-0.34
Q3'25-48%
$-0.37
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-34.29%

Stock Price CAGR

10 Years:-10.73%
5 Years:-22.06%
3 Years:+2.81%
1 Year:+245.76%

Return on Equity

10Y Avg:-55.1%
5Y Avg:-49.2%
3Y Avg:-56.0%
Last Year:-92.3%

Key Metrics

Market Cap$624M
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is ANNX in an uptrend right now?

ANNX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ANNX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is ANNX overbought or oversold?

ANNX's RSI (14) is 46. The stock is in neutral territory, neither overbought nor oversold.

Is ANNX outperforming the market?

ANNX has a Relative Strength (RS) Rating of 90 out of 99. Yes, ANNX is a market leader, outperforming 90% of all stocks over the past 12 months.

Where is ANNX in its 52-week range?

ANNX is trading at $5.71, which is 79% of its 52-week high ($7.18) and 74% above its 52-week low ($1.60).

How volatile is ANNX?

ANNX has a Beta of 2.25 and 52-week volatility of 81%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.